Amgen Bill Positions
MapLight's report on Amgen details Amgen's support for or opposition to bills in Congress. MapLight has recorded 21 bill positions taken by Amgen since January 1, 2007. These bills relate to topics including Budget, Spending, and Taxes, Government Operations and Politics, Health, Congress, Intellectual Property, and 44 other topics.
Support and opposition information is based on public documents found by MapLight, including congressional testimony, news reports, and company statements. These documents are included with the report.
Scope:
This report provides, for each of the 21 bills Amgen has taken a position on, the following information:
* Bill name, number, and sponsor.
* Bill summary and status (i.e. whether the bill is in committee, has become law, etc.).
* Amgen's position (support or opposition).
* Date Amgen's position was taken and date it was recorded by MapLight.
* Source document for the support or opposition stance.
Source documents:
Source documents for Amgen's support or opposition stance are authored by:
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* Pfizer; Dear Senator Feinstein (6 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* R&D Credit Coalition; R&D Credit Coalition Applauds House Introduction of Bipartisan Bill to Spur Innovation, Create Jobs & Boost GDP (5 pages)
* Amgen; Dear Chairman Upton, Chairman Pitts, Ranking Member Waxman, and Ranking Member Pallone: (2 pages)
* US Chamber of Commerce; Coalition for U.S.-Russia Trade Letter to Congress on Russia PNTR (12 pages)
* US Chamber of Commerce; Coalition for U.S.-Russia Trade Letter to Congress on Russia PNTR (12 pages)
* HRC; Business Coalition for Workplace Fairness, Members (1 pages)
* R&D Credit Coalition; R&D Credit Coalition applauds Senate Finance Committee action on Extenders Package (4 pages)
* And others.
Reasons to buy:
* Gauge future potential of Amgen based on whether a bill they support or oppose advances or is defeated in Congress.
* Evaluate the political activity of Amgen, including legislation of interest.
* Understand the reasoning behind Amgen's positions on legislation through content of source documents.
* Learn of other organizations that have taken the same position as Amgen on a bill (other signers).
* Learn of legislation which affects the financial prospects of Amgen.
* Learn whether bills Amgen has supported or opposed have been enacted, defeated, or are still pending.
Topics of legislation:
The bills Amgen has taken a position on cover the following topics: Budget & Economy (16), Business & Labor (16), Science, Technology, Communications, and Infrastructure (16), Government Affairs (15), Health & Welfare (13), Culture and Social Issues (10), Defense, National Security and Foreign Policy (10), Legal Affairs (8), Natural Resources (8), Education (2). The report is 146 pages long, including 21 source documents.